Anette Furevik har vært med på å utvikle de fleste vaksinene i Pharmaq. Hennes innlegg ser nærmere på en ny monovalent vaksine for å ha bedre beskyttelse mot infeksjon med Moritella viscosa, noe som har gitt veldig gode resultater fra feltforsøk.
Anette Furevik er seniorforsker i klinisk avdeling ved PHARMAQ. Hun er utdannet fiskehelsebiolog fra Universitetet i Bergen i 2009.
Head office/Production facility
Skogmo Industriområde
Industrivegen 50
N-7863 Overhalla, Norway
Tel:+47 74 28 08 00
customer.service@pharmaq.no
PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 300 employees. The company’s products are marketed in Europe, North and South America, and Asia. For further information, visit the company’s website at www.pharmaq.com
Privacy Policy. Cookie Policy. Terms of Use.
Copyright © 2022 Zoetis LLC | Design and development: KOMENT AS
